As per Data Bridge Market Research Analysis the global fluoxetine market size was valued at USD 1.03 billion in 2025 and is expected to reach USD 1.42 billion by 2033, at a CAGR of 4.10% during the forecast period
The market growth is largely fueled by the increasing prevalence of depression, anxiety disorders, obsessive-compulsive disorder, and other mental health conditions, leading to rising demand for effective antidepressant medications across both developed and emerging healthcare markets
Furthermore, growing awareness regarding mental health treatment, expanding access to psychiatric care services, and increasing preference for selective serotonin reuptake inhibitors (SSRIs) due to their favorable efficacy and safety profiles are establishing Fluoxetine as a widely adopted therapeutic solution. These converging factors are accelerating the uptake of Fluoxetine treatments, thereby significantly boosting the industry’s growth